HOME >> MEDICINE >> NEWS
The economics of prescription drugs versus OTC

Governments in several countries with public Pharmacare and in a few provinces in Canada are considering reclassifying some drugs from prescription to over-the-counter status. In a CMAJ essay, Lynd and colleagues comment on the economic effects of such changes.

The drugs being considered are used in a wide variety of chronic diseases. They include proton pump inhibitors, beta-blockers, diuretics, calcium channel blockers, angiotensin-converting enzyme inhibitors, HMG CoA reductase inhibitors, inhaled corticosteroids, short and long-acting B2 agonists, bisphosphonates and oral contraceptives. In the UK, 100 drugs are on the Medicines Control Agency's short-list for conversion to over-the-counter status. In Ontario, 8 of these drugs account for $540 million (27%) of the Ontario Drug Benefit Plan budget. In BC, 49 of these drugs account for $266 million (44%) of total Pharmacare drug expenditures.

Delisting drugs from public health insurance programs transfers the costs of the drugs to private citizens or to their private health insurance plans. In addition to cost-savings to government programs these changes are being driven by pharmaceutical companies who can expect larger markets and increased sales. There may also be economic benefits to pharmacists who while losing prescription drug revenue would gain in volume of over-the-counter sales. Also, if the drugs were regulated to behind-the-counter status (No Public Access), pharmacists would not just dispense medications, they would have a clinical and consultative role. Visits to physicians for routine control of chronic diseases might also decline.


'"/>

Contact: Dr. Larry Lynd
llynd@interchange.ubc.ca
Canadian Medical Association Journal
26-Sep-2005


Page: 1

Related medicine news :

1. Governments reliance on free market economics makes essential drug prices too high for the poor
2. Controlling prescription drug expenditures: a case report of success
3. Researchers find deadly prescription drug effects 6 years before FDA
4. Drug labels are prescriptions for mistakes
5. OPICAN study in seven Canadian cities reveals prescription opioid abuse more prevalent than heroin
6. New study on relationship between literacy and understanding of prescription labels
7. FDA approves prescription Zaditor for over-the-counter relief from itchy eyes
8. UGA researchers find high rates of off-label prescriptions
9. Hormones could be prescription for living longer
10. US suicide rates fell as fluoxetine prescriptions increased
11. Mayo Clinic leaders offer health reform vision, prescriptions

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... , ... The Visiting Nurse Association (VNA) of Somerset Hills is proud to ... unique items from across the nation, this holiday-themed event will raise funds and awareness ... VNA. The boutique will be open Saturday, November 4 (10:00 a.m. – 5:00 ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... ... DevOps and Agile Software Development, has been awarded a contract by the Center ... Purchase Agreement (BPA) aims to accelerate the enterprise use of Agile methodologies in ...
(Date:10/12/2017)... ... , ... Planet Fitness, one of the largest and fastest growing franchisors and ... flagship location in Covington, LA at 401 N. U.S. Highway 190, in January of ... Depot in the Holiday Square shopping center. Its location allows it to serve both ...
(Date:10/12/2017)... ... 12, 2017 , ... Information about the technology: , Otomagnetics ... enable prevention of a major side effect of chemotherapy in children. Cisplatin and ... For cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. ...
(Date:10/12/2017)... ... October 12, 2017 , ... Women-owned and Grand Rapids-based workplace ... Brightest in Wellness® by Best and Brightest. OnSite Wellness will be honored at ... from 7:30 a.m. to 2 p.m. at the Henry Autograph Collection Hotel, located ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), a leading global digital ... its MyDario product is expected to appear on The Dr. Oz Show ... Oz Show airs in your area: http://www.doctoroz.com/page/where-watch-dr-oz-show ... The nine-time Emmy award-winning, The Dr. Oz Show kicked off ... The segment features ...
(Date:9/23/2017)... Pa. , Sept. 22, 2017 Janssen ... a complete response letter from the U.S. Food and ... seeking approval of sirukumab for the treatment of moderately ... letter indicates additional clinical data are needed to further ... moderately to severely active RA. ...
(Date:9/19/2017)... 19, 2017 HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically ... announced three leadership team developments today:   ... ... Tom ... Veteran medical device executive Josh Stopek , PhD, who ...
Breaking Medicine Technology:
Cached News: